Opioids are primarily used to manage moderate to severe pain, but they also serve roles in cough suppression, diarrhea treatment, and end-of-life comfort care. They work by binding to specific receptors in the brain and spinal cord that dial down pain signaling. How they’re prescribed, how they’re taken, and how long they’re used varies widely depending on the situation.
How Opioids Work in the Body
Your nervous system has four types of opioid receptors, but the mu-opioid receptor is the one most responsible for pain relief. When an opioid molecule locks onto this receptor, it triggers a chain of events inside the nerve cell that ultimately quiets pain signals in two ways.
First, on the sending side of a nerve connection, opioids block calcium channels that neurons need to release chemical messengers. Fewer messengers released means fewer pain signals passed along. Second, on the receiving side, opioids open potassium channels that let potassium flow out of the cell. This makes the neuron less likely to fire. Together, these two actions reduce the transmission of pain signals from the site of injury, through the spinal cord, and up to the brain.
The same mu-opioid receptor activation also produces euphoria and a sense of calm, which is why opioids carry a risk of misuse. The pain relief and the rewarding feeling are, unfortunately, tied to the same biological pathway.
Pain Management: The Primary Use
The most common medical use of opioids is treating pain that’s severe enough that other options, like anti-inflammatory drugs or acetaminophen, aren’t sufficient on their own. This typically includes pain after surgery, serious injuries, and cancer-related pain.
For acute pain (short-term, with a clear cause), opioids are generally prescribed at the lowest effective dose for the shortest reasonable duration. The 2022 CDC prescribing guideline emphasizes that overdose risk increases continuously with dosage, with no safe cutoff. When a patient’s total opioid dose reaches or exceeds 50 morphine milligram equivalents (MME) per day, the guidelines call for extra precautions: more frequent follow-up visits and providing the overdose-reversal drug naloxone to both the patient and household members. Beyond 50 MME per day, additional increases become progressively less likely to improve pain or function relative to the added risk.
For chronic non-cancer pain, opioid use is more controversial. The same CDC guideline treats opioids as one option among many, not a default. Clinicians are encouraged to weigh whether the incremental benefit of a dose increase actually translates to better daily functioning or just accumulates risk.
Uses Beyond Pain Relief
Opioids aren’t only painkillers. Hydrocodone, for example, is combined with other ingredients to suppress cough. It works by acting directly on the cough center in the brain, reducing the urge to cough during respiratory infections. Another opioid-based drug, loperamide, targets opioid receptors in the gut wall to slow intestinal movement and treat diarrhea. Because loperamide barely crosses into the brain, it relieves diarrhea without producing pain relief or euphoria.
How Opioids Are Taken
Pills taken by mouth are the most common delivery method. They’re the least expensive, generally effective, and straightforward to use. Formulations come in two main types: immediate-release versions that act quickly and wear off in a few hours, and sustained-release versions designed to provide steady relief over 8 to 12 hours or longer.
Sustained-release and transdermal (skin patch) formulations are generally preferred for ongoing pain because they maintain more consistent drug levels and may carry a lower risk of dependence compared to fast-acting versions. Immediate-release opioids and intravenous delivery produce a sharper spike in the brain, which activates reward circuits more intensely and can accelerate tolerance.
When patients can no longer swallow, as happens for up to 70% of people nearing the end of life, clinicians switch to alternatives. Subcutaneous injections (just under the skin), intravenous lines, and feeding-tube delivery are the most reliable backup routes. Medications placed under the tongue, inside the cheek, or applied as transdermal gels have mixed evidence supporting their effectiveness.
Opioids in Palliative and End-of-Life Care
In hospice and palliative care, opioids remain essential for managing pain and easing breathing difficulty. The goals shift: rather than balancing long-term addiction risk against pain relief, the focus is comfort. Doses may be higher than what would typically be prescribed for chronic pain, because the priority is quality of life in the time remaining.
Even so, palliative care specialists don’t prescribe carelessly. Sustained-release formulations are still generally preferred because they offer steadier symptom control. Rapid-onset fentanyl (delivered through nasal sprays or tablets that dissolve in the mouth) and patient-controlled intravenous pumps are reserved for specific situations and aren’t appropriate for every patient, even at end of life.
Tolerance, Dependence, and Addiction
These three terms describe different things, though they often overlap. Tolerance means your body adapts to the drug so that the same dose produces less effect over time. This happens with most side effects within the first few days of starting opioids, with two notable exceptions: constipation and itching tend to persist for as long as you take the medication.
Physical dependence means your body has adjusted to the drug’s presence, and stopping abruptly causes withdrawal symptoms like nausea, muscle aches, anxiety, and insomnia. Dependence is a predictable physiological response, not a moral failing. It can develop in anyone who takes opioids regularly for more than a few weeks.
Opioid use disorder (OUD) is something different. It’s diagnosed when opioid use causes significant problems in a person’s life: loss of control over use, cravings, inability to meet responsibilities, or continued use despite harm. Diagnosis requires at least two of these characteristic features within a 12-month period. Many people who develop physical dependence never develop OUD, but the risk is real, particularly with higher doses and longer durations of use. People may initially take opioids for legitimate pain but eventually continue primarily to avoid withdrawal, which can blur the line between dependence and disorder.
Side Effects to Expect
The most common side effects include constipation, nausea, drowsiness, dizziness, and itching. Drowsiness and dizziness typically improve within the first few days as your body adjusts, but you should expect them to affect driving and tasks that require concentration, especially when starting a new opioid or increasing the dose.
Constipation is nearly universal and doesn’t improve with time. It results from opioids slowing gut movement through the same receptor activation that provides pain relief. Most prescribers recommend starting a laxative or stool softener at the same time as the opioid rather than waiting for the problem to develop.
The most dangerous side effect is slowed breathing. Opioids reduce the brain’s sensitivity to rising carbon dioxide levels, which is the main signal that tells you to breathe. At high doses, or when combined with alcohol, sedatives, or benzodiazepines, this can become life-threatening.
Overdose Reversal With Naloxone
Naloxone is an opioid antagonist, meaning it competes for the same receptors but produces no opioid effects. It essentially bumps opioid molecules off their receptors and blocks new ones from binding. It’s available as a nasal spray or injection and acts within minutes.
The critical limitation is that naloxone only works in the body for 30 to 90 minutes. Since many opioids last longer than that, a person can slip back into overdose after naloxone wears off. Stronger synthetic opioids like fentanyl may require multiple doses of naloxone to reverse. This is why calling emergency services remains essential even after administering naloxone successfully.
Global Access Remains Unequal
While opioid overprescription has driven a crisis in North America, much of the world faces the opposite problem. Medical opioid consumption is heavily concentrated in developed countries across Europe, North America, and Oceania. In lower-income countries, access remains insufficient to meet basic medical needs for pain relief after surgery, during cancer treatment, and at end of life. Only 18% of all morphine manufactured worldwide, about 32.5 tons, is used directly for pain relief. The rest goes toward manufacturing other pharmaceutical products. For billions of people, the challenge isn’t opioid overuse but the near-total absence of adequate pain management.